Exploring the Safety of Anticoagulants Post-Brain Hemorrhage

This chapter delves into findings from the Prestige AF trial presented at the International Stroke Conference, focusing on the use of direct oral anticoagulants in atrial fibrillation patients with a history of brain hemorrhages. It emphasizes the balance between reducing ischemic strokes and managing hemorrhage risks, while also addressing the need for ongoing research in this complex clinical area.